MeiraGTx Holdings plc (MGTX) stock
MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.14−0.18 (-2.16%)
Close on Nov 19, 2026Market cap $781.79MP/E 11.5Yield –
MeiraGTx pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
MeiraGTx's pe ratio was 13.6× on Nov 11, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 13.6× | – |
See a number that looks wrong?